CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients
CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients
The aim of the study is to compare the effect of group-cognitive-behavioral therapy
 (CBT)versus treatment as usual with the selective serotonin reuptake inhibitor sertraline, in
 patients with diagnosis of temporal lobe epilepsy (TLE) and depressive disorder.
patients with temporal lobe epilepsy and depression will be enrolled into one of two
 treatment modality. The first group will receive 12 group cognitive behavioral sessions. CBT
 is a psychotherapy focused on the recognition and change of distorted thoughts and
 maladaptive behaviors.

 The second group will receive treatment with the selective serotonin reuptake inhibitor
 sertraline or citalopram for 12 weeks. This antidepressant is wide used to treat depression
 in patients with TLE.
Inclusion Criteria:

 -  With Major depressive disorder according to criteria from the fourth edition of the
 Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

 -  Diagnosed with TLE according to the criteria of the International League Against
 Epilepsy

 -  Literates had sign an informed consent

 -  Patients on antidepressant treatments will be allowed to participate only if they had
 been at stable doses for more than 8 weeks and still show signs of significant
 depression

 Exclusion Criteria:

 -  Patients with high risk of suicide who required hospitalization

 -  Patients who abused or are dependent on drugs

 -  Those with a history of head trauma six months prior to the interview

 -  Patients who have any condition that would prevent them from understanding the study
 or the psychotherapeutic process, such as mental retardation, psychosis, delirium,
 dementia, etc

 -  Patients who have previously received CBT

 -  Patients who have started, an antidepressant drug the last 8 weeks